MIRXES plans to enter the Indonesian market and has signed a memorandum of understanding with PT DIASTIKA BIOTEKINDO
MIRXES-B (02629.HK) announced that it has signed a memorandum of understanding with the Indonesian listed company PT DIASTIKA BIOTEKINDO. According to this, both parties agree to cooperate in the registration and commercialization of molecular diagnostic tests and related instruments for early detection and diagnosis of cancers with high incidence and high mortality rates in Indonesia
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments